SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-030664
Filing Date
2017-08-09
Accepted
2017-08-08 19:36:54
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 AKCEA THERAPEUTICS, INC. 10-Q 6-30-2017 form10q.htm 10-Q 896117
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12093
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11929
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5791
  Complete submission text file 0001140361-17-030664.txt   4628172

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT akca-20170630.xml EX-101.INS 816143
6 XBRL TAXONOMY EXTENSION SCHEMA akca-20170630.xsd EX-101.SCH 41654
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20170630_cal.xml EX-101.CAL 48800
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20170630_def.xml EX-101.DEF 221484
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20170630_lab.xml EX-101.LAB 574706
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20170630_pre.xml EX-101.PRE 321084
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38137 | Film No.: 171016138
SIC: 2834 Pharmaceutical Preparations